Find and Pitch Jounalists, Get Your Story Covered

Tags: Software & Services Software Platforms IT Automation Apple cell biology, Craniofacial, developmental biology, DNA repair, genetics, oxidative stress

	Profile	Recent Articles on Subject
1	Amy Baxter Pharma Voice Scientist, inventor, former pediatrician. Atlanta, Georgia pain relieftechnologyinnovation	Oncology, obesity and more: Where pharma R&D is headed in 2025 - 9 days ago 2024 PharmaVoice 100s: Clinical Trial Pros - about 2 months ago How Roche plans to fill a projected $8B sales gap - 3 months ago The hunt for the brain’s biomarkers - 6 months ago FDA’s platform designation aims to ease R&D pain points - 7 months ago Execs from Bayer, Kite and Orca sound off on their launch strategies for cell and gene therapies - 7 months ago 4 offbeat biotechs making a splash in the life sciences - 8 months ago As antimicrobial resistance looms large, a nonprofit teams up with Big Pharma to intervene - 9 months ago Pharma CFOs need R&D vigilance in tough economic times - 10 months ago
2	Ed Silverman STAT News Pharmalot columnist. Senior writer at STATnews. pharmaceutical industry	STAT+: Tuberculosis R&D funding is up, but still short of goals and dominated by a few players, report finds - 12 days ago STAT+: Pharmalittle: We’re reading about Moderna R&D cuts, Lilly plant investments and more - 3 months ago
3	Meagan Parrish Pharma Voice Senior editor @industrydive. Pharma world follower. Wisconsin, USA pharmaceuticalsjournalismparenting	What’s next for 23andMe? - 15 days ago 2024 PharmaVoice 100s: Trailblazers - 2 months ago Neuro drugs are still faltering, despite rising investment - 5 months ago Pharma’s R&D gamble: picking pipeline winners in a risky field - 7 months ago Neurvati touts fresh, ‘synergistic’ investment model in neuroscience R&D - 10 months ago Astellas’ science chief on the leap into new technologies - 11 months ago PharmaVoice’s Crystal Ball: What’s next in drug innovation and clinical trials - 12 months ago PharmaVoice 100s: Clinical trial gurus - about 1 year ago
4	Allison DeAngelis STAT News Reporter at STAT. Formerly Insider, BBJ. biopharmastartupsventure capital	STAT+: Recursion, the AI drug development company, cuts more jobs after finalizing Exscientia merger - 29 days ago
5	Adam Spatacco Motley Fool Community for top investors. Investingcommunity	This is Huge News For Eli Lilly Investors - 2 months ago
6	Matthew Herper STAT News Writes at STAT. Biology's century. Undisclosed biologydatajournalism	STAT+: Moderna touts research progress as it cuts R&D spending by $1.1 billion - 3 months ago STAT+: J&J to emphasize cancer drugs and stop much of its vaccine research - about 1 year ago
7	Jason Mast STAT News Writing about science, medicine. ScienceMedicineBusiness	STAT+: Moderna touts research progress as it cuts R&D spending by $1.1 billion - 3 months ago
8	Stewart Burnett Automotive World Voice of the remarketing & used car sectors. remarketingautomotive industry	Research Cooperation: BMW Group and University of Zagreb Optimize Battery Cell Production with Artificial Intelligence - 3 months ago
9	US Department of Energy Clean Technica Covers cleantech industry. Focus on EVs, renewables. World CleantechElectric VehiclesSolar EnergyWind EnergyTeslaEnergy Storage	Funding Notice: $43 Million Available for EV Battery Research & Development - 5 months ago U.S. Vehicle Technologies Office Selects 27 Small Businesses to Advance Innovative Clean Transportation R&D - 5 months ago
10	Nathan Eddy InformationWeek Surrey, England	Software Engineering, Startup Thinking - 6 months ago

Journalists covering Research & Development